BGB-21447

BGB-21447 · BeOne Medicines

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BGB-21447, covering 2025-11-10 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies [Phase 1]